Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford is part of country-wide trials to identify accurate and quick blood tests that can diagnose dementia.

Nurse taking blood from a patient

World-class research teams at Dementias Platform UK based at the Department of Psychiatry, University of Oxford, and University College London will capitalise on recent breakthroughs in potential dementia blood tests, and generate the evidence needed for them to be used in the NHS within the next five years.

The teams make up the Blood Biomarker Challenge - a multi-million pound award given by Alzheimer’s Society, Alzheimer’s Research UK and the National Institute for Health and Research and Gates Ventures including £5 million raised by players of People’s Postcode Lottery. The project aims to revolutionise dementia diagnosis.

Both teams will recruit participants from sites spread across the country, to ensure their findings are applicable to the whole of the UK’s diverse population.

Read the full story on Department of Psychiatry website